Longer survival of liver transplant recipients with hepatitis virus coinfections

Clinical Transplantation

Volumn 21, Issue 2, 2007, Pages 258-264

  Rifai, Kinan ^a   Wedemeyer, Heiner ^a   Rosenau, Jens ^a   Klempnauer, Jürgen ^a   Strassburg, Christian P ^a   Manns, Michael P ^a   Tillmann, Hans L ^b  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Hepatitis B; Hepatitis C; Hepatitis delta virus; Liver transplantation; Survival analysis; Viral coinfection

Indexed keywords

ANTIVIRUS AGENT; HEPATITIS B ANTIBODY; LAMIVUDINE;

ADULT; ARTICLE; CONTROLLED STUDY; DELTA AGENT HEPATITIS; DISEASE COURSE; FEMALE; GRAFT RECIPIENT; GRAFT SURVIVAL; HEPATITIS B; HEPATITIS C; HUMAN; IMMUNOCOMPETENCE; LIVER CELL CARCINOMA; LIVER FAILURE; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RETRANSPLANTATION; STATISTICAL SIGNIFICANCE; SUPERINFECTION; SURVIVAL RATE; SURVIVAL TIME; TREATMENT OUTCOME;

ADULT; COMORBIDITY; FEMALE; HEPATITIS B; HEPATITIS C; HEPATITIS D; HUMANS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 33947712806     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2006.00636.x     Document Type: Article

References (42)

1. Ockenga J, Tillmann HL, Trautwein C et al. Hepatitis B and C in HIV-infected patients. Prevalence and prognostic value. J Hepatol 1997: 27: 18.
2. Telfer P, Sabin C, Devereux H et al. Progression of HCV-associated liver disease in a cohort of hemophilic patients. Br J Haematol 1994: 87: 555.
3. Pol S, Fontaine H, Carnot F et al. Predictive factors for the development of cirrhosis in parenteraly acquired chronic hepatitis C: A comparison between immunocompetent and immunocompromised patients. J Hepatol 1998: 29: 12.
4. Tillmann HL, Heiken H, Knapik -Botor A et al. Infection with GB virus C infection and reduced mortality among HIV-infected patients. N Engl J Med 2001: 345: 715.
5. Watt G, Kantipong P, de Souza M et al. HIV-1 suppression during acute scrub-typhus infection. Lancet 2000: 356: 475.
6. Elvander M, Baule C, Persson M et al. An experimental study of a concurrent primary infection with bovine respiratory syncytial virus (BRSV) and bovine viral diarrhoea virus (BVDV) in calves. Acta Vet Scand 1998: 39: 251.
7. Benhamou Y, Bochet M, Di Martino V et al. Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. The Multivirc Group. Hepatology 1999: 30: 1054.
8. Greub G, Ledergerber B, Battegay M et al. Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: The Swiss HIV Cohort Study. Lancet 2000: 356: 1800.
9. Balik I, Onul M, Tekeli E, Caredda F. Epidemiology and clinical outcome of hepatitis D virus infection in Turkey. Eur J Epidemiol 1991: 7: 48.
10. Fattovich G, Giustina G, Christensen E et al. Influence of hepatitis delta virus infection on morbidity and mortality in compensated cirrhosis type B. The European Concerted Action on Viral Hepatitis (Eurohep). Gut 2000: 46: 420.
11. Liaw YF, Chen YC, Sheen IS et al. Impact of acute hepatitis C virus superinfection in patients with chronic hepatitis B virus infection. Gastroenterology 2004: 126: 1024.
12. Fattovich G, Stroffolini T, Zagni I, Donato F. Hepatocellular carcinoma in cirrhosis: Incidence and risk factors. Gastroenterology 2004: 127: 35.
13. Lai CL, Ratziu V, Yuen MF, Poynard T. Viral hepatitis B. Lancet 2003: 362: 2089.
14. Poynard T, Yuen MF, Ratziu V, Lai CL. Viral hepatitis C. Lancet 2003: 362: 2095.
15. Gane E. The natural history and outcome of liver transplantation in hepatitis C virus-infected recipients. Liver Transpl 2003: 9: 28.
16. Kim WR, Poterucha JJ, Kremers WK et al. Outcome of liver transplantation for hepatitis B in the United States. Liver Transpl 2004: 10: 968.
17. Samuel D, Zignego AL, Reynes M et al. Long-term clinical and virological outcome after liver transplantation for cirrhosis caused by chronic delta hepatitis. Hepatology 1995: 21: 333.
18. Huang EJ, Wright TL, Lake JR et al. Hepatitis B and C coinfections and persistent hepatitis B infections: Clinical outcome and liver pathology after transplantation. Hepatology 1996: 23: 396.
19. Taniguchi M, Shakil AO, Vargas HE et al. Clinical and virologic outcomes of hepatitis B and C viral coinfection after liver transplantation: effect of viral hepatitis D. Liver Transpl 2000: 6: 92.
20. Berenguer M, Terrault NA, Piatak M et al. Hepatitis G virus infection in patients with hepatitis C virus infection undergoing liver transplantation. Gastroenterology 1996: 111: 1569.
21. Tillmann HL, Heringlake S, Trautwein C et al. Antibodies against the GB virus C envelope 2 protein before liver transplantation protect against GB virus C de novo infection. Hepatology 1998: 28: 379.
22. Rambusch EG, Nashan B, Tillmann HL et al. De novo hepatitis B infection after liver transplantation - evidence for the need of active hepatitis B vaccination of liver transplantation candidates. Z Gastroenterol 1998: 36: 939.
23. Samuel D, Müller R, Alexander G et al. Liver transplantation in European patients with hepaitis B surface antigen. N Engl J Med 1993: 329: 1842.
24. Rosenau J, Bahr MJ, Tillmann HL et al. Lamivudine and low-dose hepatitis B immune globulin for prophylaxis of hepatitis B reinfection after liver transplantation - Possible role of YMDD mutations prior to transplantation as a risk factor for reinfection. J Hepatol 2001: 34: 895.
25. Féray C, Caccamo L, Alexander GJ et al. European collaborative study on factors influencing outcome after liver transplantation for hepatitis C. Gastroenterology 1999: 117: 619.
26. Böker KH, Dalley G, Bahr MJ et al. Long-term outcome of hepatitis C virus infection after liver transplantation. Hepatology 1997: 25: 203.
27. Kalliomaki M, Salminen S, Arvilommi H et al. Probiotics in primary prevention of atopic disease: A randomised placebo-controlled trial. Lancet 2001: 357: 1076.
28. Wagner -Jauregg J. Über die Einwirkung der Malaria auf die progressive Paralyse. Psychiatrisoh-neurologische Wochensch 1919: 20: 251.
29. Steinmüller T, Seehofer D, Rayes N et al. Increasing applicability of liver transplantation for patients with hepatitis B-related liver disease. Hepatology 2002: 35: 1528.
30. Lerut JP, Donataccio M, Ciccarelli O et al. Liver transplantation and HBsAg-positive postnecrotic cirrhosis: Adequate immunoprophylaxis and delta virus co-infection as the significant determinants of long-term prognosis. J Hepatol 1999: 30: 706.
31. Adam R, Mc Master P, O'Grady JG et al. Evolution of liver transplantation in Europe: Report of the European Liver Transplant Registry. Liver Transpl 2003: 9: 1231.
32. Wedemeyer H, Tillmann HL, Tegtmeyer B et al. Infection with multiple hepatitis viruses. Evidence for suppression of HCV replication by HDV and HBV. Hepatology 2001: 34: 223.
33. Tsai SL, Liaw YF, Yeh CT et al. Cellular immune responses in patients with dual infection of hepatitis B and C viruses: Dominant role of hepatitis C virus. Hepatology 1995: 21: 908.
34. Guptan RC, Thakur V, Malhotra V, Sarin SK. Clinical implications of viral activity in dual infection with hepatitis B and C in chronic liver disease. J Assoc Physicians India 2002: 50: 651.
35. Mohamed Ael S, al Karawi MA, Mesa GA. Dual infection with hepatitis C and B viruses: Clinical and histological study in Saudi patients. Hepatogastroenterology 1997: 44: 1404.
36. Zarski JP, Bohn B, Bastie A et al. Characteristics of patients with dual infection by hepatitis B and C viruses. J Hepatol 1998: 28: 27.
37. Sagnelli E, Pasquale G, Coppola N et al. Influence of chronic coinfection with hepatitis B and C virus on liver histology. Infection 2004: 32: 144.
38. Chu CM, Sheen IS, Liaw YF. Low-level hepatitis C viremia and humoral immune response to NS4 in chronic hepatitis B virus-hepatitis C virus coinfection. Scand J Gastroenterol 2004: 39: 778.
39. Charlton M, Seaberg E, Wiesner R et al. Predictors of patient and graft survival following liver transplantation for hepatitis C. Hepatology 1998: 28: 823.
40. Feray C, Gigou M, Samuel D et al. Incidence of hepatitis C in patients receiving different preparations of hepatitis B immunoglobulins after liver transplantation. Ann Intern Med 1998: 128: 810.
41. Willems B, Ede M, Marotta P et al. Anti-HCV human immunoglobulins for the prevention of graft infection in HCV-related liver transplantation, a pilot study. J Hepatol 2002: 36: 32.
42. Adam R, Cailliez V, Majno P et al. Normalised intrinsic mortality risk in liver transplantation: European Liver Transplant Registry study. Lancet 2000: 356: 621.